Literature DB >> 36068793

Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapy.

Salma El-Behaedi1, Spencer Ng1, Parul K Goyal1, Jennifer N Choi1.   

Abstract

Entities:  

Keywords:  COVID-19 vaccine; immunotherapy

Year:  2022        PMID： 36068793      PMCID： PMC9436862          DOI： 10.1016/j.jdcr.2022.08.043

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN： 2352-5126


× No keyword cloud information.
  10 in total

Review 1.  Cutaneous adverse effects of the immune checkpoint inhibitors.

Authors:  Lindsey K Collins; M Shane Chapman; Joi B Carter; Faramarz H Samie
Journal:  Curr Probl Cancer       Date:  2016-12-14       Impact factor: 3.187

Review 2.  Programmed death-1 & its ligands: promising targets for cancer immunotherapy.

Authors:  Rajeev K Shrimali; John E Janik; Rasha Abu-Eid; Mikayel Mkrtichyan; Samir N Khleif
Journal:  Immunotherapy       Date:  2015-08-07       Impact factor: 4.196

3.  Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.

Authors:  Martina Sanlorenzo; Igor Vujic; Adil Daud; Alain Algazi; Matthew Gubens; Sara Alcántara Luna; Kevin Lin; Pietro Quaglino; Klemens Rappersberger; Susana Ortiz-Urda
Journal:  JAMA Dermatol       Date:  2015-11       Impact factor: 10.282

4.  Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines.

Authors:  Lacey B Robinson; Xiaoqing Fu; Dean Hashimoto; Paige Wickner; Erica S Shenoy; Adam B Landman; Kimberly G Blumenthal
Journal:  JAMA Dermatol       Date:  2021-08-01       Impact factor: 11.816

Review 5.  mRNA vaccine for cancer immunotherapy.

Authors:  Lei Miao; Yu Zhang; Leaf Huang
Journal:  Mol Cancer       Date:  2021-02-25       Impact factor: 27.401

6.  Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.

Authors:  Devon E McMahon; Erin Amerson; Misha Rosenbach; Jules B Lipoff; Danna Moustafa; Anisha Tyagi; Seemal R Desai; Lars E French; Henry W Lim; Bruce H Thiers; George J Hruza; Kimberly G Blumenthal; Lindy P Fox; Esther E Freeman
Journal:  J Am Acad Dermatol       Date:  2021-04-07       Impact factor: 11.527

7.  The first case report of Pityriasis lichenoides chronica following COVID-19 mRNA vaccination.

Authors:  Noha Mohammed Dawoud; Huma Aslam; Ishraga Mahmoud Ali; Marwa Mohammed Dawoud
Journal:  Dermatol Ther       Date:  2022-03-21       Impact factor: 3.858

Review 8.  Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review.

Authors:  Jennifer M Yoest
Journal:  Immunotargets Ther       Date:  2017-10-10

9.  Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit?

Authors:  K Hussain; A Kawsar; J Weir; L Au; S Turajlic; J Larkin; L Fearfield
Journal:  Clin Exp Dermatol       Date:  2021-08-13       Impact factor: 4.481

10.  Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer.

Authors:  Lea Daniello; Mariam Elshiaty; Farastuk Bozorgmehr; Jonas Kuon; Daniel Kazdal; Hannah Schindler; Rajiv Shah; Anna-Lena Volckmar; Fabienne Lusky; Leonore Diekmann; Stephan Liersch; Martin Faehling; Thomas Muley; Mark Kriegsmann; Karolina Benesova; Albrecht Stenzinger; Michael Thomas; Petros Christopoulos
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.